These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15985381)

  • 1. Regulation of the mammalian heart function by nitric oxide.
    Massion PB; Pelat M; Belge C; Balligand JL
    Comp Biochem Physiol A Mol Integr Physiol; 2005 Oct; 142(2):144-50. PubMed ID: 15985381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-Nitrosylation of cardiac ion channels.
    Gonzalez DR; Treuer A; Sun QA; Stamler JS; Hare JM
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):188-95. PubMed ID: 19687749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of 25-hydroxycholesterol-mediated suppression of atrial β1-adrenergic responses.
    Odnoshivkina JG; Averin AS; Khakimov IR; Trusov NA; Trusova DA; Petrov AM
    Pflugers Arch; 2024 Mar; 476(3):407-421. PubMed ID: 38253680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation.
    Mancardi D; Pagliaro P; Ridnour LA; Tocchetti CG; Miranda K; Juhaszova M; Sollott SJ; Wink DA; Paolocci N
    Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The goldfish Carassius auratus: an emerging animal model for comparative cardiac research.
    Filice M; Cerra MC; Imbrogno S
    J Comp Physiol B; 2022 Jan; 192(1):27-48. PubMed ID: 34455483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hypoxia Tolerance of the Goldfish (
    Filice M; Mazza R; Leo S; Gattuso A; Cerra MC; Imbrogno S
    Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32604810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Nitric Oxide on Voltage-Gated K⁺ Currents in Human Cardiac Fibroblasts through the Protein Kinase G and Protein Kinase A Pathways but Not through S-Nitrosylation.
    Bae H; Choi J; Kim YW; Lee D; Kim JH; Ko JH; Bang H; Kim T; Lim I
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2017 May; 106():29-44. PubMed ID: 28365422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway.
    Mendes-Júnior Ld; Guimarães DD; Gadelha DD; Diniz TF; Brandão MC; Athayde-Filho PF; Lemos VS; França-Silva Mdo S; Braga VA
    Front Physiol; 2015; 6():243. PubMed ID: 26379557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart.
    Schlüter KD; Schulz R; Schreckenberg R
    Front Physiol; 2015; 6():65. PubMed ID: 25814956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control systems in cardiac aging.
    Quarles EK; Dai DF; Tocchi A; Basisty N; Gitari L; Rabinovitch PS
    Ageing Res Rev; 2015 Sep; 23(Pt A):101-15. PubMed ID: 25702865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfur as a signaling nutrient through hydrogen sulfide.
    Kabil O; Vitvitsky V; Banerjee R
    Annu Rev Nutr; 2014; 34():171-205. PubMed ID: 25033061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroxyl (HNO) for treatment of acute heart failure.
    Arcaro A; Lembo G; Tocchetti CG
    Curr Heart Fail Rep; 2014 Sep; 11(3):227-35. PubMed ID: 24980211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2S and its role in redox signaling.
    Kabil O; Motl N; Banerjee R
    Biochim Biophys Acta; 2014 Aug; 1844(8):1355-66. PubMed ID: 24418393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Hepa Wash® treatment in pigs with acute liver failure.
    Al-Chalabi A; Matevossian E; V Thaden AK; Luppa P; Neiss A; Schuster T; Yang Z; Schreiber C; Schimmel P; Nairz E; Perren A; Radermacher P; Huber W; Schmid RM; Kreymann B
    BMC Gastroenterol; 2013 May; 13():83. PubMed ID: 23668774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
    Mannino GC; Sesti G
    Mol Diagn Ther; 2012 Oct; 16(5):285-302. PubMed ID: 23018631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide effects depend on different mechanisms in different regions of the rat heart.
    Derici K; Samsar U; Demirel-Yilmaz E
    Heart Vessels; 2012 Jan; 27(1):89-97. PubMed ID: 21311889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.
    Tocchetti CG; Stanley BA; Murray CI; Sivakumaran V; Donzelli S; Mancardi D; Pagliaro P; Gao WD; van Eyk J; Kass DA; Wink DA; Paolocci N
    Antioxid Redox Signal; 2011 May; 14(9):1687-98. PubMed ID: 21235349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms.
    Aquilante CL
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):359-72. PubMed ID: 20222815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.